Background: We recently showed that acquired immunodeficiency syndrome (AIDS) dementia is associated with activated infection of microglia, neurons, and astrocytes by HIV-1. However, it is doubtful whether infection per se is responsible for the dramatic symptoms associated with AIDS dementia. The purpose of this study was to determine the histologic distribution of messenger RNAs (mRNAs) of several cytokines that have been implicated in AIDS pathogenesis and to correlate this ex-
INTRODUCTION
Clinically obvious central nervous system (CNS) -disease is found in many people with acquired immunodeficiency syndrome (AIDS), especially in the later stages of their disease. The most severe form of this disease is AIDS dementia, where the patient typically experiences difficulty with a variety of cognitive and motor functions. Observations from virologic and pathologic studies have suggested that infection of the CNS by human immunodeficiency virus 1 (HIV-1) occurs commonly in the early stages of the disease (1, 2) . The clinical manifestations of AIDS de-infected cells contained spliced HIV-1 RNA (9) . This suggested that direct viral infection of neurons was responsible, in part, for the devastating clinical findings of AIDS dementia. However, it is doubtful that HIV-1 infection is the only factor responsible for AIDS dementia.
There are many theories that attempt to explain the CNS damage associated with HIV-1. These include gpl20 neuronal toxicity, immunologic-mediated damage due to common epitopes such as gp4l and an astrocyte cell surface antigen, and the production of cytokines, such as tumor necrosis factor (TNF), by microglial cells and/or astrocytes, which hinders neuronal function and can cause oligodendroglial cell death and, thus, demyelinization (5, 10, 11) . Other cytokines that have been implicated in the pathogenesis of AIDS, either by modulating viral expression and/or inducing damage in the involved tissues, include inducible nitric oxide synthetase (iNOS), macrophage inflammatory protein a (MIP-I a) and MIP-1, (12,1 3) .
A major impediment to the understanding of the role of cytokine expression in AIDS dementia is that viral and host nucleic acids may be difficult to localize directly by standard in situ hybridization, as the copy number may be below the 10-copy per cell detection threshold (9, 14, 15) . Several investigators including ourselves have detected in situ PCR-amplified HIV-1 DNA and cDNA as well as human mRNA that were not evident with standard in situ hybridization (9, (14) (15) (16) 
MATERIALS AND METHODS Patient Selection
Brain and spinal cord tissue that was fixed in 10% buffered formalin were studied from seven patients who had died of AIDS. Four of these people had severe CNS symptomatology, including three cases of AIDS dementia, whereas the other three had no specific CNS symptomatology. These cases were chosen in order to compare the histologic distribution of the virus in a wide pathologic and clinical spectrum. Multiple regions of the brain were studied in the patients with AIDS dementia, corresponding to regions of severe (cerebrum) and minimal (cerebellum and midbrain) symptomatology. None of the cases was used in our prior study of AIDS dementia (9) except for Case 1; in this study, different tissue samples were analyzed. Tissues from the CNS of five patients who had died from a variety of causes and who had no risk factors or evidence of AIDS were studied as negative controls.
In Situ Hybridization The probes used for HIV-1 detection were SKI 9 and SK102 (Perkin-Elmer Corp., Norwalk, CT, U.S.A.) and were labeled with digoxigenindUTP. These correspond the gag region. The standard in situ hybridization protocol used for these oligoprobes has been previously published (9, 14, 15) . Briefly, after protease digestion (2 mg/ml of trypsin at 37°C for 10-15 min) the probe (50 ng/ml in a solution of 10% formamide, 5% dextran sulfate, and 300 mM NaCl) and target DNA are simultaneously denatured by heating to 100°C for 5 min. The chromogen NBT/ BCIP (Digene Diagnostics, Gaithersburg, MD, U.S.A.) produces a dark blue hybridization signal, whereas the counterstain nuclear fast red stains nuclei and cytoplasm pink. PCR in Situ Hybridization and RT in Situ PCR Our procedure for detection of PCR-amplified HIV-1 DNA has been published previously (9, 14, 15 one reaction mixture by the use of rTth, as previously described (17) . Viral RNA detection was performed with the gag-specific primers listed above. Primers for TNF detection were previously reported (9) . The primers for iNOS, MIPla, and MIP-l1(3 mRNA detection were generously provided by Drs. Michael Bukrinsky and Barbara Sherry (12, 13) . For colocalization of viral and host RNAs, two separate RT in situ PCR reactions were performed on the same tissue section. For viral RNA, the reporter nucleotide was digoxigenin and for the human mRNA it was 3H dCTP, used at a ratio of 5:1 with unlabeled dCTP, as previously reported (14) .
RESULTS
Fifteen tissues from the CNS of seven patients with AIDS and five tissues from five patients without evidence of HIV-1 infection taken from the cerebrum, cerebellum, and brain stem were studied. Of the seven patients with AIDS, four had long-standing and severe clinical CNS disease that correlated with widespread CNS histologic changes that included marked neuronal loss evident on routine histologic staining, demyelinization, and the microglial nodules and multinucleated giant cells diagnostic of HIV-1 encephalitis. Two of these patients (age 37 and 52, respectively) had long-standing dementia, one (age 5) had severe retardation of motor and developmental skills and the other (age 5) had a 2-year history of seizure disorder of unknown etiology. Their CD4 counts were all less than 34 at the time of death. Of the other three people with AIDS, each showed either minimal or "nonspecific" histologic CNS changes that corresponded to a lack of clinical evidence of AIDS dementia. Their ages were 5, 38, and 39 years, and each had a CD4 count of less than 30.
The 20 tissues (including the five controls) were analyzed for sequences homologous to HIV-1 DNA using standard in situ hybridization with and without prior PCR amplification. Serial sections were studied using the probe SKl9, and probe SK102, respectively. HIV (Fig. 1) . In the four people with severe CNS symptomatology, many other positive cells were seen in the tissues from the cerebrum (Table 2). The HIV-1-infected cells were most nu- merous in the area of the gray matter, although viral-positive cells were also evident in the white matter (Fig. 1) . Although provirus was most readily identified in the tissues from areas of demyelinization, microglial nodules, and/or neuronal loss, it was also evident in areas of the tissues from the cerebrum where these pathologic features were not evident. The percentage of HIV-1-positive cells from the cerebral tissues of the three patients with AIDS dementia and the one with a seizure disorder ranged from 3 to 11% of the microglial cells/macrophages, 8 to 15% of the neurons, and 1 to 3% of the astrocytes. Determination of cellular phenotype was done by immunohistochemical colabeling, as previously reported (9) . To determine if HIV-1 distribution in the people with AIDS dementia correlated with CNS topography, tissues from the cerebellum and midbrain were studied, as the patients showed few symptoms ascribable to these regions. This data, also compiled in Table 2 , demonstrated that much fewer HIV-1 DNA-positive cells were found in these regions.
To ascertain whether the infection was latent or active with viral transcription, the tissues were analyzed for HIV-1 RNA with RT in situ PCR and the gag-specific primer pairs. The number and distribution of HIV-1 RNA-positive cells from the cerebral sections from the four people with severe CNS symptomatology was equivalent to that of PCR-amplified HIV-1 DNA (Table 2 and Fig. 2 ). The specificity of the signal with RT (Table 1) .
To determine if expression of TNFa, iNOS, MIP-la, and MIP-1, correlated with AIDS dementia, serial (subjacent) sections that were 4 ,um distal to the samples used for viral nucleic acid analysis were studied. In the four people with severe CNS symptomatology, cells with TNF, iNOS, MIP-l1a, and MIP-1,B cDNA were readily identified in those areas where many viral-infected cells were evident ( Table 2 ). Most of the cells expressing these cytokines were microglial cells/macrophages or astrocytes (Fig. 3) , although occasional neurons expressed iNOS and MIP-la and MIP-1,B. Expression of these cytokines was less evident from these people with AIDS dementia in the sections of cerebellum and midbrain, where viral-infected cells were less frequent (Table 2) . Similarly, cytokine transcription was not evident in the tissues of the AIDS patients who did not have CNS-related symptoms (Table 1) . To determine if viral-infected cells were expressing cytokines, colabeling of viral RNA and cytokine mRNA was performed. These experiments demonstrated that cytokine expression occurred primarily in the HIV-1-negative cells that were in close proximity to viral infected cells (Fig. 4) . Specifically, in the areas where there were many HIV-1-positive cells, the number of HIV-1-negative cells that were expressing a cytokine was 5-fold greater than the number of HIV-1-positive cells.
DISCUSSION
The primary findings of this study were that expression of TNF, iNOS, MIP-1a, and MIP-1 f3 was strongly correlated to AIDS dementia, occurred in regions where HIV-1-infected cells were most plentiful, and localized primarily to the viralnegative cells. This strongly suggests that the pathogenesis of AIDS dementia is based on cellular damage due to direct infection by HIV-1, amplified by cytokine expression in neighboring uninfected cells.
Cytokine production plays an essential role in the pathophysiology of AIDS by modulating viral activation, inflammatory cell recruitment and function, and tissue damage (12, 13 (19) ; both are also chemotactic for macrophages. iNOS could contribute to CNS disease by increasing the cytotoxicity of macrophages, by direct cytotoxicity, by disturbance of blood flow, and by possibly enhancing the activity of cytokines such as TNF (20, 21 (9, (14) (15) (16) . The number and range of cells with the provirus varied considerably in the tissues from patients with AIDS dementia versus those without CNS symptomatology. In patients with AIDS dementia, infected astrocytes and microglia were noted, and up to 18% of neurons in sections from the cerebrum were viral positive. In patients without CNS symptomatology, far fewer infected cells were seen: less than 1% of microglial cells in a given section contained the provirus, and infected neurons or astrocytes were not identified. The infection in people without CNS symptomatology appeared to be latent, as the HIV-1 DNA positive cells were negative for viral RNA. One may speculate that this represents early, latent infection with entry of the virus from the peripheral blood to the CNS via monocytes. In comparison, the results from patients with severe CNS symptomatology suggest that the infection by HIV-1 was productive. The ratio of HIV-1 DNA/ HIV-1 RNA detection in these tissues was about 1. Furthermore, the equivalent detection of HIV-1 RNA with the primers that correspond to the gag region and the exons from the tat and rev regions is the pattern seen in productive in vitro infection, suggesting the presence of multiply spliced and full-length genomic transcripts (9, 18) .
In summary, this data suggests a model for AIDS dementia where the initial event is viral entry into the CNS early in the disease process. Perivascular microglial cells may remain latently infected for years. An essential step towards AIDS dementia is activation of viral infection. This is associated with the spread of the virus to many cells in the CNS, including neurons and astrocytes. Although direct damage to astrocytes and neurons would certainly explain part of the disease process, the cellular response, including expression of TNF, iNOS, MIP-la and MIP-1f3, clearly could enhance local tissue damage, increase viral transcription, and ultimately lead to the devastating symptoms characteristic of AIDS dementia.
